PT-141
A melanocortin receptor agonist studied for MC3R/MC4R signaling in research models.
Research Overview
PT-141 (bremelanotide) is a cyclic heptapeptide analog of α-MSH that acts as an agonist at the melanocortin receptors, principally MC3R and MC4R. Research models study its central-nervous-system melanocortin-pathway signaling.
Unlike peripheral vasoactive compounds, it is investigated for receptor-mediated central signaling, which is the focus of its research literature.
Specifications
| Compound | PT-141 (Bremelanotide) |
| Classification | Wellness research compound |
| Molecular weight | 1,025.2 g/mol |
| Sequence / Form | Ac-Nle-cyclo(-Asp-His-D-Phe-Arg-Trp-Lys)-OH |
| Purity | ≥99% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
